Chinese biotech Sino biological Inc. and U.S. biotech Life Technologies have announced a partnership for worldwide product distribution and product development.
Pfizer Inc. and Mylan Inc. have signed an agreement to develop, manufacture, distribute, and market generic drugs in Japan.
A team of Australian and U.S. scientists have shown that addiction to opioids such as morphine and heroin can be blocked in rats.
Gilead Sciences Inc. has signed an agreement with three Indian companies to promote access to generic versions of its HIV drug.
Healthcare products provider Covidien announced last week the official opening of its China Technology Center (CTC) Research and Development (R&D) facility in Shanghai.
Australian biotech Novogen announced on Friday that it has entered into a merger agreement with Delaware-based Kai Medical.
Sanofi Pasteur announced on Thursday promising efficacy results of its dengue vaccine candidate in an efficacy trial conducted in Thailand.
Takeda Pharma announced yesterday the initiation of a Phase 3 clinical trial involving 400 patients across Japan, Hong Kong, South Korea, and Taiwan.
Researchers in Australia have shown that two different viral vaccines - used simultaneously in chickens - have combined to produce new infectious viruses.